NImmune Biopharma ("NImmune"), a private late-stage precision inflammation and immunology ("I&I") biopharmaceutical company, today announced that Executive Chairman, President and CEO Dr. Josep ...

Israel’s Teva Pharmaceutical Industries US unit and French pharma major Sanofi today announced positive results from the RELIEVE UCCD long-term extension (LTE) study of duvakitug, an investigational ...

Rallybio Corporation , a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced positive ...

BREAKWATER trial Cohort 3 analysis demonstrated statistically significant and clinically meaningful improvement in ...

During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50 years of patient ...

Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, rezpegaldesleukin (rezpeg), in atopic dermatitis (AD).

Backed Solution to Support Relaxation and Nervous System Balance Lake Oswego, Oregon–(Newsfile Corp. –) – Functional Brands Inc. (NASDAQ: MEHA), a leading innovator ...

Iberdomide has the potential to be the first approved CELMoD agentThe U.S. FDA has granted Breakthrough Therapy Designation and Priority Review for this indication and assigned a target action date of ...

A bacterium that infects roughly half the world’s population, often without producing symptoms for decades, may be responsible for the vast majority of stomach cancer cases projected to occur in the ...

Tea is delicious and good for you, so we tested out myriad teas from a dozen top brands and spoke with dietitians to find the ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra ® across nine diverse patients ...

In this study, the researchers analyzed more than 275 million T-cell receptor sequences from over 2,200 individuals and used artificial intelligence ...